跳转至内容
Merck

185779

Sigma-Aldrich

2-氯苯酚

≥99%

别名:

o-Chlorophenol

登录查看公司和协议定价


About This Item

线性分子式:
ClC6H4OH
CAS号:
分子量:
128.56
Beilstein:
1905114
EC號碼:
MDL號碼:
分類程式碼代碼:
12352100
PubChem物質ID:
NACRES:
NA.22

品質等級

化驗

≥99%

形狀

liquid

折射率

n20/D 1.558 (lit.)

bp

175-176 °C (lit.)

mp

8 °C (lit.)

溶解度

alcohol: freely soluble
diethyl ether: freely soluble
water: slightly soluble

密度

1.241 g/mL at 25 °C (lit.)

官能基

chloro

SMILES 字串

Oc1ccccc1Cl

InChI

1S/C6H5ClO/c7-5-3-1-2-4-6(5)8/h1-4,8H

InChI 密鑰

ISPYQTSUDJAMAB-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

高压平推流反应器中近临界和超临界水中 2-氯苯酚氧化的动力学已进行了研究。利用Co掺杂TiO2纳米颗粒催化剂研究了水溶液中2-氯苯酚的光催化降解

2-氯苯酚用作Suzuki偶联和氯化反应的反应物,并且也参与氧化反应形成相应的醌。

應用

2-氯苯酚用于在填充床反应器中通过 Cu(II)O介导的反应合成多氯二苯并二噁英和二苯并呋喃

訊號詞

Danger

危險分類

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Corr. 1B

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 2

閃點(°F)

147.2 °F - closed cup

閃點(°C)

64.0 °C - closed cup

個人防護裝備

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

A detailed mechanism of the surface-mediated formation of PCDD/F from the oxidation of 2-chlorophenol on a CuO/silica surface.
Lomnicki S and Dellinger S.
The Journal of Physical Chemistry A, 107(22), 4387-4395 (2003)
2-Chlorophenol oxidation in supercritical water: Global kinetics and reaction products.
Li R, et al.
AIChE Journal, 39(1), 178-187 (1993)
Photocatalytic degradation of 2-chlorophenol by Co-doped TiO2 nanoparticles.
Barakat MA, et al.
Applied Catalysis. B, Environmental, 57(1), 23-30 (2005)
Julio Alonso-Padilla et al.
PLoS neglected tropical diseases, 8(12), e3259-e3259 (2014-12-05)
The discovery of new therapeutic options against Trypanosoma cruzi, the causative agent of Chagas disease, stands as a fundamental need. Currently, there are only two drugs available to treat this neglected disease, which represents a major public health problem in
Thi Thu Nga Nguyen et al.
The Journal of antimicrobial chemotherapy, 70(3), 731-738 (2014-10-23)
HIV resistance to the integrase inhibitor raltegravir in treated patients is characterized by distinct resistance pathways. We hypothesize that differences in the in vivo dynamics of HIV resistance to raltegravir are due to the genetic context of the integrase present

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门